Lv1
30 积分 2024-07-05 加入
High-Dose Furmonertinib in Patients With EGFR-Mutated NSCLC and Leptomeningeal Metastases: A Prospective Real-World Study
20小时前
已完结
Furmonertinib: First Approval
10天前
已完结
Immune checkpoint inhibitors in patients with cancers of unknown primary
1个月前
已关闭
Molecular guided therapies: a practice-changing step forward in cancer of unknown primary management
1个月前
已完结
Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone
1个月前
已完结
New clinical trials in CUP and a novel paradigm in cancer classification
1个月前
已完结
Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary
1个月前
已完结
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
1个月前
已完结
Diagnostic and therapeutic management of cancer of an unknown primary
1个月前
已完结
AI-based pathology predicts origins for cancers of unknown primary
1个月前
已完结
皖公网安备34019202002308
